Non-invasive urinary screening for aromatic L-amino acid decarboxylase deficiency in high-prevalence areas: a pilot study
| Autor: | Y P Yuen, Chloe Miu Mak, Han-Chih Hencher Lee, Sidney Tam, Kin-Cheong Eric Yau, Kwok-Yin Chan, Tak-Shing Siu, Albert Yan-Wo Chan, Ching-Wan Lam, Chi-Kong Lai |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
medicine.medical_specialty Urinary system Clinical Biochemistry PNPO Pilot Projects Urine Biochemistry Gastroenterology Gas Chromatography-Mass Spectrometry chemistry.chemical_compound Cerebrospinal fluid Internal medicine medicine Prevalence Humans Neurotransmitter Amino Acid Metabolism Inborn Errors Aromatic L-amino acid decarboxylase medicine.diagnostic_test Lumbar puncture Chemistry Biochemistry (medical) Infant General Medicine Aromatic-L-Amino-Acid Decarboxylases Hong Kong Urine organic acids |
| Zdroj: | Clinica chimica acta; international journal of clinical chemistry. 413(1-2) |
| ISSN: | 1873-3492 |
| Popis: | Background The diagnosis of aromatic l -amino acid decarboxylase (AADC) deficiency, one of the pediatric neurotransmitter disorders, is classically made with plasma enzyme level or cerebrospinal fluid (CSF) neurotransmitter profile, while both are technically demanding and the latter requires the invasive lumbar puncture. So far less than 100 cases have been reported worldwide with 20% from Taiwan. It was postulated that the condition might have been under-diagnosed among Chinese populations and a non-invasive screening tool should be developed in areas with high prevalence. Methods Urine metabolic profiles performed by gas chromatography–mass spectrometry (GC-MS) in a 31-month period were retrospectively reviewed: those with vanilmandelic acid concentration lower than one percentile plus the presence of 3-o-methyldopa were defined as positive and the patients were further evaluated. Results Among 1046 metabolic profiles (from 845 patients) reviewed, 3 profiles from 2 patients were screened positive: both cases had compatible CSF neurotransmitter profiles and the diagnosis was further confirmed by genetic analysis of DDC gene. 13 negative urinary metabolic profiles from 7 patients who had CSF neurotransmitters analyzed were identified as controls: all 7 CSF neurotransmitter profiles were not compatible for AADC deficiency. Conclusions The GC-MS-based urine metabolic profiling was shown to be a satisfactory screening tool for AADC deficiency. Further confirmation can be performed by mutation analysis in the DDC gene, thus avoiding risks of lumbar puncture. We advocate all ethnic Chinese patients presenting with dystonia have their urine organic acids analyzed before proceeding to CSF neurotransmitters analysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect